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Abstract 
TF antigen binding lectins from dietary source PNA, ACA, ABL, JAC and SRL from 
Sclerotium rolfsii have been reported to induce diverse effects on cancer cell proliferation by 
different mechanisms. This study aimed to compare effects of these lectins on growth and 
cell cycle progression in colon cancer HT29 and SW620 cells. As reported SRL, ABL and 
JAC inhibited whilst PNA and ACA increased cell proliferation. ABL and JAC treated HT29 
cells showed increased cell population in G0/G1 phase. PNA, ACA, ABL and JAC increased 
SW620 cell population in S and decreased in G2/M phase. In contrast SRL and JAC 
increased hypodiploid population in both the cells. PNA and ACA reduced whereas SRL and 
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ABL diminished cell cyclin D1 expression. SRL, PNA and ACA also reduced cellular cyclin 
D3 level while SRL, ABL and JAC reduced cyclin E levels. ABL decreased CDK5 levels 
while SRL and ACA completely abolished CDK5 expression.  All the lectins completely 
abolished cyclin D2 expression. These results not only confirms growth regulatory effects of 
TF-binding  lectins but also indicates different effects of these lectins on cell growth is 
associated with regulation on expression of cell cycle associated proteins in G1-S phase and 
on cell cycle progression.
Keywords:, TF binding dietary lectins, SRL, Colon cancer cells, Cell cycle, Proliferation, 
Inhibition, Apoptosis.
Abbreviations: Thomsen Friedenreich antigen (TF),   PNA (Peanut agglutinin), ACA 
(Amaranthus caudatus agglutinin), SRL (Sclerotium rolfsii lectin), ABL (Agaricus bisporus 
lectin) and JAC (Jacalin).
Introduction
Protein glycosylation is one of the important post-translational modifications (PTM) 
and half of the human proteins are estimated to be glycosylated [1]. Glycosylation plays very 
important role in protein folding, stability and in cell signalling. Changes of protein 
glycosylation occur in various pathophysiological conditions. In cancer, alteration of protein 
glycosylation, such as the increased appearance of Galactoseβ1-3-Nacetyl-galactosamine α-
O-Ser/Thr (TF antigen) [1, 2] is common and is correlated with cancer malignancy and 
progression, which are sites for TF binding lectins.  Hence consuming foods such as peanuts, 
mushrooms, jackfruit and others that are rich in TF specific lectin content is of concern, as 
these lectins are known to resist digestion, survive gut passage and bind to gastrointestinal 
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cells or enter the circulation intact, maintaining full biological activity [5]. Although 
glycosylation changes are often secondary to hyperplastic or malignant changes in the 
epithelium, they allow altered epithelial cell interactions with the environment. For example 
in the gut, it results in altered interaction of the gastrointestinal epithelium with carbohydrate 
binding proteins (lectins) in the food stuff, an effect that has been proposed to lead to the 
intestinal epithelium hyper-proliferation [3, 4]. 
Lectins are known bind to specific carbohydrate structures in reversible manner. The 
carbohydrate binding specificity of lectins has been exploited to identify carbohydrate 
changes on cell surfaces in cancer cells. There are many studies showing that lectin-glycan 
interaction on the cell surface can affect cell behaviours through activation of a variety of 
signalling events [6-8]. One of the most common lectin effects are on growth of the cells 
either stimulatory or inhibitory [9]. For example, the presence of the TF binding lectin from 
peanuts (PNA) is mitogenic to both the colon carcinoma cells [3] and for normal human 
colonic explants [4]. TF-antigen binding Amaranthus caudatus agglutinin (ACA) also 
stimulates cell proliferation of colon cancer cells [10]. On the other hands, TF binding lectins 
from the edible mushroom Agaricus bisporous (ABL) and jackfruit Artocarpus integrifolia 
(JAC) have shown to inhibit cell proliferation of several colon and breast cancer cells in a 
non-cytotoxic manner [10,11]. The ABL-mediated cell growth inhibition is associated with 
ABL internalization [17] and subsequent blockade of NLS-dependent nuclear protein import 
[18]. The growth inhibitory effect of JAC is associated with tyrosine phosphorylation of the 
putative human HLA-DR-associated protein I (PHAPI, also known as the tumor suppressor 
pp32) that causes release of PP2A protein phosphatase from association with PHAPI, 
allowing increased phosphatase activity of PP2A[19]. Recent studies from our laboratory 
have shown that another TF antigen binding lectin from Sclerotium rolfsii (SRL), isolated 
Page 22 of 48
http://mc.manuscriptcentral.com/nc Email: HNUC-peerreview@journals.tandf.co.uk
Nutrition and Cancer: An International Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
S. Belur et al. 4
from sclerotial bodies of Sclerotium rolfsii fungus, shows to inhibit cell proliferation by 
inducing cellular apoptosis in different cancer cells including HT29 human colon cancer cells 
[12-14,15]. It has been suggested that the diverse effects of these TF-binding lectins on cell 
proliferation are attributed to the subtle differences in the fine sugar specificity of these TF-
binding lectins [10].
Considering the presence of TF binding lectins in the dietary sources and their close 
resemblance in the structure and fine sugar specificity with SRL, the aim of this study was to 
compare effects of all these five TF-antigen binding lectins on cell cycle in human colon 
cancer HT29 and SW620 cells so as to gain further information of their diverse effects on cell 
proliferation and understanding their effect on cell cycle and expression of various cyclins.
Materials and Methods
Materials
Bovine serum albumin (BSA), protease inhibitor cocktail, nonidet P-40 (NP-40), 
ethylenediaminetetra-acetic acid (EDTA), 2-mercaptoethanol, Ribonuclease A, Triton X-100, 
trypan blue, Calcein-AM,  glycine, DAPI, formaldehyde and propidium iodide were obtained 
from Sigma Chemical Co. (St. Louis, USA). PNA, ACA, ABL and JAC were purchased from 
Vector Laboratories, CA, USA. Acrylamide, bisacrylamide, Tris and sodium dodecyl 
sulphate (SDS) were obtained from GE Life Sciences (Pittsburgh, PA, USA). Dulbecco’s 
Modified Eagle Medium (DMEM) and Fetal Bovine Serum (FBS) were from Gibco by Life 
technologies Pvt. Ltd. USA. PVDF membrane was procured from Millipore, USA. 
Antibodies to cyclin D1, D2 and D3, cyclin E, CDK5 and p21 were procured from Cell 
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Signalling technologies, Beverly, USA. Species-specific HRP-labelled secondary antibodies 
were procured from Bio- Rad, Hercules, USA. Chemiluminescence kit was procured from 
Bio-Rad Laboratories Inc. USA. All other chemical used were of analytical grade. 
Cell culture
The human colon cancer HT29 cells were obtained from the European Cell Culture 
Collection via the Public Health Laboratory Service (Porton Down, Wiltshire, UK). SW620 
cells were kind gift from Prof. Karunagaran D, from Department of Biotechnology, IIT 
Madras, India.The cells were cultured in DMEM supplemented with 10 % FBS, 100 units/ml 
penicillin, 100 μg/ml streptomycin (complete DMEM) at 37 °C in 5 % CO2.
Purification of Sclerotium rolfsii lectin
SRL was purified from sclerotial bodies as reported before [20]. Briefly, SRL was 
extracted with 50 mM acetate buffer containing 100 mM NaCl (pH 4.3) and subjected to 30% 
methanol precipitation followed by ion exchange chromatography on CM cellulose matrix 
and finally purified on Superdex G-75 gel filtration column. 
Assessment of Cell growth by Calcein-AM method
Briefly, sub-confluent HT29 and SW620 cells were seeded (4 × 104 cells/ml) in 96-
well plates in DMEM with 10% FBS (complete medium) for 24 h. The cells were treated 
with SRL, ABL, JAC, PNA and ACA (each 25µg/ml) for 48h in serum-free DMEM with 
0.5% BSA (incomplete medium) and maintained in humidified atmosphere (37°C, 5% CO2) 
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for 48h. After 48h, cells were labelled with 10 μM Calcein AM at 37°C for 30 min in a CO2 
incubator, lysed with 100 μL of lysis buffer (50 mM Tris–HCl, pH 6.8, with 5% SDS and 2% 
mercaptoethanol). The fluorescent intensity was read using Tecan M200 pro microplate 
reader with an excitation wave length of 485 nm and an emission wave length of 535 nm.
Cell cycle analysis
Sub-confluent HT29 and SW620 cells were treated with or without SRL, ABL, JAC, 
PNA and ACA (25 µg/ml) for 24 and 48 h before harvested by gentle trypsinization. Cells 
were washed in PBS twice and fixed in 70% chilled ethanol for 30 min at 4 °C. Cells were 
then washed once in PBS and treated with 50 µl of Ribonuclease A (DNase-free 5 mg/ml in 
PBS,) for 10 min at room temperature and stained with 450 µl propidium iodide (50 µg/ml in 
PBS) for 2 h in the dark. DNA content of HT29 cells was analysed on FL-3 channel of flow 
cytometer (FC-500 Beckman Coulter) equipped with 488 nm argon laser at linear scale. Data 
was analysed using CXP analysis software for distribution of cells in different phases of the 
cell cycle. DNA content of SW620 cells was analysed on FL-2 channel of flow cytometer 
(BD Accuri C6) and the data was analysed using BD Accuri C6 Software.
Western blotting
 Sub-confluent HT29 cells were treated with SRL, ABL, JAC, PNA and ACA (25 
µg/ml) in serum free media at 37°C for 24 h. After treatment, the cells were lysed using RIPA 
lysis buffer (120 mM NaCl, 1.0% Triton X- 100, 20 mM Tris–HCl, pH 7.5, 10% glycerol, 2 
mM EDTA, Protease inhibitor cocktail; Sigma Aldrich) and total protein was electrophoresed 
on 12% SDS–polyacrylamide gels and then blotted on to PVDF membranes. The membranes 
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were blocked with 3% BSA and were probed with primary antibodies (1:1000) to cyclin D1, 
cyclin D2, cyclin D3, cyclin E, CDK5 and Waf1/p21 for overnight at 4°C, followed by 
incubation of species-specific secondary antibodies (1:1000) for 1h. Finally the bands were 
visualized using chemiluminescence with Immun-StarTM HRP Luminol/Enhancer (BIO-
RAD). β-actin was used as loading control. The bands were analysed using Image Studio Lite 
Ver 5.2 software.
Results
Effect of TF binding lectins on cell growth in HT29 and SW620 cells 
As reported previously, the presence of each of the TF binding dietary lectins ABL, 
JAC, PNA, ACA and SRL, showed to affect growth of HT29 cells. PNA and ACA increased 
HT29 cell proliferation by 34.37 ± 3.85 and 6.90 ± 8.31%  respectively whilst SRL, ABL and 
JAC caused growth inhibition by 39.19 ± 2.83, 15.86 ± 0.75 and 3.14 ± 3.37% respectively at 
48h (Fig. 1.a). In SW620 cells, PNA increased cell proliferation by 17.7 ± 1.6 while the other 
four lectins, SRL, ABL ACA and JAC inhibited cell growth by 31.5 ± 1.36, 14.5 ± 2.35, 24.0 
± 0.20 and 19.8 ± 0.72% respectively at 48h (Fig1.b)
TF binding lectins show different effects on cell cycle
HT29 and SW620 cells treated with SRL, ABL, JAC, PNA and ACA were stained 
with propidium iodide (PI) and were subjected for cell cycle analysis by flow cytometry. 
After 24h treatment of HT29 cells, the proliferative lectins PNA and ACA did not show any 
significant effect on cell cycle compared to the untreated control cells. In contrast the anti-
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proliferative ABL and JAC increased the cell population in G0/G1 phase and decreased cells 
in both S and G2/M-phase (Fig 2). Unlike PNA, ACA, ABL and JAC, SRL increased 
apoptotic/hypodiploid population and reduced the cell population in all the phases of cell 
cycle. After 48h PNA, ACA, ABL and JAC increased the cells in S phase, SRL, ABL and 
JAC decreased the cells in G2/M phase and SRL continued to increase the cells in 
hypodiploid phase (Table 1, Fig. 2). In SW620 cells after 24h treatment, PNA, ACA, ABL 
and JAC all showed to increase cell population in S phase, and all the five lectins decreased 
the cell population in G2/M phase. Both SRL and JAC increased the cells in hypodiploid 
phase. After 48h treatment, PNA ACA and ABL increased the cells in G2/M phase. The anti-
proliferative lectins SRL and JAC decreased the cells in G2/M phase. SRL significantly 
increased hypodiploid population in SW620 cells compared to control or to other TF binding 
lectins, in consistent to its observed effect on apoptosis induction in HT 29 cells as reported 
earlier [11,19] (Table 2, Fig. 3). In SW620 cells, PNA and ACA slightly decreased the cell 
population in G0/G1, S and increased in G2/M-phase. Whereas SRL, ABL and JAC 
continued to increase the cells in hypodiploid phase and decreased the cells in S-phase.
Effect of TF binding lectins on expression of cell cycle-related proteins in G1-S phase 
transition
Having observed the different effects on cell cycle of these TF-binding lectins, we 
then compared the expressions of cell cycle related proteins in G1-S phase transition (Fig. 4). 
Cyclin D1 expression was significantly diminished in response to SRL and ABL treatment 
(0.25 and 0.06 fold respectively), whereas PNA, JAC and ACA treatment slightly reduced 
cyclin D1 expression (0.26, 0.45 and 0.62 fold respectively). All the lectins completely 
diminished the expression of cyclin D2. Cyclin D3 expression was significantly reduced to 
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0.14 by SRL and to 0.67 and 0.48 by PNA and ACA respectively compared to lectin 
untreated control taken as 1. ABL and JAC showed no effect on cyclin D3 expression. Cyclin 
E expression was reduced in SRL and JAC treated cells to 0.36 and 0.49, respectively, but not 
by PNA, ACA and ABL. It is noted that reduction of cyclin E expression was more 
prominent in SRL treated cells (0.36) when compared to ABL or JAC treated cells (0.72 and 
0.49 respectively). CDK5 expression was totally abolished by the treatment of SRL and ACA 
while it was only partially reduced by ABL treatment. 
Discussion
Alteration of cell surface glycosylation allows altered interactions of the intestinal 
epithelium with TF-binding lectins from dietary (PNA, JAC and ACA), microbial (ABL and 
SRL) or endogenous human origins [23, 24]. All these TF-binding lectins have previously 
been shown to affect growth of human colon cancer cells in cell culture [25, 12]. The present 
study showed that the presence of each of these TF binding lectins affect growth of human 
colon cancer cells in culture and produced different effect on the expression of cell cycle-
associated proteins.
PNA and ACA showed strong and mild proliferative effect, respectively, whereas 
ABL and SRL showed inhibitory effects on HT29 cell growth as reported before [4, 10]. JAC 
showed no significant growth inhibition at this concentration [10-12]. This lack of effect of 
JAC on cell proliferation may be related to the different concentrations of the lectins used or 
the different assay times or methods used.  In earlier studies, thymidine incorporation assay 
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was used to assess effect of PNA, ACA, ABL and JAC on growth of HT29 cells, in the 
present study Calcien-AM assay was used. 
Although all these lectins recognise TF antigen, these lectins are different in their sugar 
binding specificity toward addition on TF by other sugar residues. PNA binding to TF 
requires free hydroxyl groups at C-3 and C-6 of Gal but not at C-6 of GalNAc [26], whereas 
ACA binding requires free hydroxyl groups at C-4 of Gal and C-4 of GalNAc [27]. ABL 
binding to TF requires a free hydroxyl group at C-6 of GalNAc, but is not affected by 
substitution at C-3 or C-6 of Gal [26], whilst JAC also requires free hydroxyl group at C-6 of 
GalNAc, similar to ABL, but unlike ABL, also requires free hydroxyl group at C-4 of 
GalNAc [28]. SRL binding to TF requires a free axial hydroxyl groups at C4 of GalNAc 
similar to JAC and also C2 of Gal unlike other TF binding lectins [29]. Apart from these 
binding differences, these TF binding lectins also have distinct binding affinity towards TF 
anomers. SRL, ACA and JAC recognize only the “α anomer” of TFD (Galβ1- 3GalNAcα-
Sp8; TFβα) whereas PNA and ABL recognizes only the “β anomer” (Galβ1-3GalNAcβ–Sp8; 
TFββ). Hence SRL resembles JAC and ACA more closely than PNA and ABL in binding to 
TF antigen [29]. 
The presence of lectins is known to influence cell cycle in culture. For example; 
Agrocybe aegerita lectin (AAL) which binds to N-acetylgalactoseamine, and Legumi secchi 
lectin, which has binding specificity to N-acetylglucosamine and mannose, decrease cells in 
the G2/M phase in cancer cells. AAL has also been shown to increase population in 
hypodiploid/apoptotic phase of cell cycle [30,31].  Astragalus mongholicus lectin showed to 
arrest HeLa cell cycle in S phase [32]. SRL has been shown to decrease cell population in all 
the phases of cell cycle and increase hypodiploid phase in human epithelial ovarian cancer 
PA1 cells [31]. In the present study, treatment of HT 29 cells with PNA and ACA for 24h did 
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not show any effect on cell cycle. In contrast, the anti-proliferative lectins ABL and JAC 
increased the cell population in G0/G1 phase and decreased cells in both S and G2/M-phase, 
suggesting ABL and JAC treatment arrested the cells at G0/G1 phase. SRL treatment of the 
cells showed to reduce cell population in all the phases of cell cycle thereby shifting the cells 
to apoptotic/hypodiploid phase in a time dependent manner. In SW620 cells, all the TF 
binding lectins except SRL increased the cell population in G0/G1 and S phase and all the 
lectins decreased the cells in G2/M phase. SRL and JAC also increased SW620 cells in 
hypodiploid phase. At 48h, PNA and ACA treatment showed to slightly increase the cell 
population in G0/G1 and S phase, in HT 29 cells, whereas ABL and JAC marginally 
decreased the cells in G2/M phase. In SW620 cells, PNA and ACA slightly decreased the cell 
population in G0/G1, S and increased in G2/M-phase. Taken together, these results suggest 
that ABL and JAC inhibit HT 29 cell growth by arresting the cells in G0/G1 phase whilst the 
proliferative effect of PNA and ACA is linked with decrease of cells in G0/G1 phase and 
increase in S phase. In consistent to its effect on apoptosis induction, SRL increased 
hypodiploid population and decreased cells in all the three phases G0/G1, S and G2/M of cell 
cycle. These results are in line with our earlier observation that several genes involved in cell 
cycle pathways were significantly affected by SRL suggesting that the initial signalling 
cascades lead to the disruption of cell cycle and induction of apoptosis [20].
Eukaryotic cell division is tightly regulated and the key fate decisions are made in the 
G1 phase of cell cycle i.e. whether the cell should proliferate or not. In cell cycle, there are a 
set of cell cycle regulatory proteins like, D-type cyclin proteins, cyclin D1, D2 and D3, 
cyclin-dependent kinases (CDK)- 2, -4 and-6 that control the progression of cells from G1 to 
S phase [33]. Cyclin D-CDK4/CDK6 complex is known to phosphorylate the retinoblastoma 
susceptibility gene product Rb in mid- to late G1 phase and triggers the onset of S phase by 
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inducing the release of E2F transcription factor which transcriptionally activates genes 
involved in the activation and maintenance of DNA synthesis [35].
In the present study, all the five TF binding lectins differentially regulated cyclins 
involved in G1 to S transition phase. PNA, ACA and JAC slightly reduced cyclin D1 
expression whereas SRL and ABL totally diminished D1 expression which falls in line with 
our previous reports that SRL induces cellular apoptosis in HT 29 cells[12]. Cyclin D2 
expression was completely abolished by the presence of each of the lectins compared to 
control. Surprisingly all the five lectins have shown to reduce the expression of Cyclin D2 
including PNA and ACA contradicting their proliferative response. Cyclin D3 expression was 
significantly reduced by SRL and moderately reduced by PNA and ACA. In contrast cyclin 
D3 levels were not affected either by ABL or JAC. Overexpression of cyclins D1, D2 and D3 
has been reported in a large number of tumours. Overexpression of cyclins D1 and/or D2, but 
not cyclin D3, is reported to correlate with colon carcinogenesis [35]. Inhibition of cyclin D1 
expression has shown to inhibit growth and tumorigenicity of human colon cancer cells [37]. 
Hence down-regulation of cyclin D1 and D2 levels by SRL, ABL and JAC consequently 
arrests the cells at G0/G1 phase. In contrast to cyclin D1 and D2, cyclin D3 has been shown 
to play positive role in colon epithelial cell differentiation but not in colon carcinogenesis 
[38]. Proliferative lectins PNA and ACA may promote cell proliferation by decreasing cell 
cyclin D3 levels which is known to induce differentiation. 
Cyclin E is another important G1 phase regulator which regulates normal cell 
proliferation and development. Cyclin E expression in HT29 cells was markedly reduced by 
the presence of SRL, ABL and JAC, but not by PNA and ACA. Cyclin E/CDK2 complex 
regulates progression of cells from the G1 to the S phase. Cyclin E deregulation plays a role 
in tumorigenesis [39] and its overexpression is correlated with carcinogenesis of many 
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cancers including colorectal cancer [40]. Cyclin E is required by S phase entry of cells in 
growth. The presence of SRL, ABL and JAC, but not PNA and ACA reduced cyclin E 
expression in HT29 cells; this is consistent with ABL and JAC effect on cell rest in G1-S 
phase.
The presence of ABL reduced CDK5 levels and SRL and ACA completely abolished 
in SRL and ACA- CDK5 expression. CDK5 is a proline-directed serine/threonine kinase and 
controls various cellular events, including cytoskeletal organization, cell adhesion, membrane 
trafficking, cell cycle exit and neuronal differentiation, and thereby regulates multiple aspects 
of brain development and function [41]. CDK5 Overexpression is shown to occur in 
metastatic tumors in comparison in primary colon tumors. Inhibition of CDK5 expression by 
gene knockdown or small molecule inhibitors reduced cell proliferation and migration, 
increased cell death and arrested cells in the G2/M transition in vitro and halted tumor 
progression and tumor weight in vivo [42]. A decreased level of CDK5 in HT29 cells by the 
presence of SRL and ABL is in consistent with the growth inhibitory effect of these two 
lectins supports in those cells. Antiproliferative lectins SRL and ABL have reduced the 
overall expression of Cyclin D1, D2, D3, Cyclin E and CDK5which fall in line with their 
ultimate response.
In conclusion, all the TF binding dietary  lectins and SRL produce different effects on 
proliferation of human colon cancer cells and these effects are associated with different 
influences of the lectins on expression of cell cycle associated proteins or cyclins and cell 
cycle progression.   
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Figure Legends
Fig. 1. Effect of TF binding lectins on cell proliferation
HT29 (a) or SW620 (b) cells were treatment with PNA, ACA, SRL, ABL and JAC (25µg/ml) 
in serum free DMEM for 48h before cell proliferation was analysed by Calcein-AM assay as 
described in the materials and methods section. (*p<0.05, **p<0.01, ***p<0.001)
Fig. 2. Effect of TF binding lectins on cell cycle progression in HT29 cells
HT29 cells were incubated with PNA, ACA, SRL, ABL and JAC (25 µg/ml) for 24 (A) and 
48h (B). Cells were stained with PI and then analysed on FL3 channel of flow cytometer. X-
axis represents DNA content of cells and the Y-axis represents cell number. C, D, E and F 
represent cell population in hypodiploid/apoptotic, G0/G1, S and G2/M phases, respectively.
Fig. 3. Effect of TF binding lectins on cell cycle progression in SW620 cells
SW620 cells were incubated with PNA, ACA, SRL, ABL and JAC (25 µg/ml) for 24 (A) and 
48h (B). Cells were stained with PI and then cells was analysed on FL-2 channel of flow 
cytometer. M1, M2, M3 and M4 represent cell population in hypodiploid/apoptotic, G0/G1, S 
and G2/M phases, respectively at 24 h and 48 h. 
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Fig. 4. Effect of TF binding lectins on expressions of cell cycle-associated proteins in G1-
S phase
HT29 cells were treated with PNA, ACA, SRL, ABL and JAC (25 µg/ml) for 24 h and whole 
cell lysate was electrophoresed and transblotted on to PVDF membrane and probed with 
antibodies against cyclin D1, cyclin D2, cyclin D3, CDK5, cyclin E and p21. β-Actin was 
used as loading contr l. Data are representative of two similar experiments. The bands were 
analysed using Image Studio Lite Ver 5.2 software and change in expression is mentioned 
compared to control.
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Fig. 1. Effect of TF binding lectins on cell proliferation 
HT29 (a) or SW620 (b) cells were treatment with PNA, ACA, SRL, ABL and JAC (25µg/ml) in serum free 
DMEM for 48h before cell proliferation was analysed by Calcein-AM assay as described in the materials and 
methods section. (*p<0.05, **p<0.01, ***p<0.001) 
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Fig. 2. Effect of TF binding lectins on cell cycle progression in HT29 cells 
HT29 cells were incubated with PNA, ACA, SRL, ABL and JAC (25 µg/ml) for 24 (A) and 48h (B). Cells were 
stained with PI and then analysed on FL3 channel of flow cytometer. X-axis represents DNA content of cells 
and the Y-axis represents cell number. C, D, E and F represent cell population in hypodiploid/apoptotic, 
G0/G1, S and G2/M phases, respectively. 
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Fig. 3. Effect of TF binding lectins on cell cycle progression in SW620 cells 
SW620 cells were incubated with PNA, ACA, SRL, ABL and JAC (25 µg/ml) for 24 (A) and 48h (B). Cells were 
stained with PI and then cells was analysed on FL-2 channel of flow cytometer. M1, M2, M3 and M4 
represent cell population in hypodiploid/apoptotic, G0/G1, S and G2/M phases, respectively at 24 h and 48 
h. 
136x80mm (300 x 300 DPI) 
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Fig. 4. Effect of TF binding lectins on expressions of cell cycle-associated proteins in G1-S phase 
HT29 cells were treated with PNA, ACA, SRL, ABL and JAC (25 µg/ml) for 24 h and whole cell lysate was 
electrophoresed and transblotted on to PVDF membrane and probed with antibodies against cyclin D1, cyclin 
D2, cyclin D3, CDK5, cyclin E and p21. β-Actin was used as loading control. Data are representative of two 
similar experiments. The bands were analysed using Image Studio Lite Ver 5.2 software and change in 
expression is mentioned compared to control. 
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Table 1: Effect of TF binding lectins on different phases of cell cycle in HT29 cells at 24 
and 48h.
TF antigen binding lectins
Time point Control  PNA ACA SRL ABL JAC
24h 3.67 5.11 5.38 19.87 7.71 8.70
Hypodiploid
48h 7.55 9.40 8.83 38.79 7.75 7.14
24h 76.60 76.03 77.05 66.15 84.55 80.02
G0/G1
48h 79.71 75.47 74.21 54.98 77.61 79.00
24h 10.10 9.49 8.33 8.45 6.62 8.94
S
48h 7.03 9.38 10.67 4.24 10.34 9.36
24h 9.58 9.16 8.87 5.50 1.10 2.08
Pe
rc
en
ta
ge
 o
f c
el
ls
 in
 d
iff
er
en
t p
ha
se
s
G2/M
48h 5.56 5.50 6.03 1.83 4.19 4.29
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Table 2: Effect of TF binding lectins on different phases of cell cycle in SW620 cells at 24 
and 48h.
TF antigen binding lectins
Time point Control PNA ACA SRL ABL JAC
24h 2.52 2.02 2.15 11.13 1.62 4.86
Hypodiploid
48h 2.96 2.62 2.80 24.07 3.97 9.31
24h 67.58 68.54 65.64 67.60 67.26 66.60
G0/G1
48h 69.62 69.17 70.79 61.48 67.81 68.70
24h 8.93 11.86 12.58 7.88 11.08 9.87
S
48h 15.74 14.18 14.01 6.29 13.74 10.99
24h 22.85 17.56 19.60 13.37 20.02 18.65
Pe
rc
en
ta
ge
 o
f c
el
ls
 in
 d
iff
er
en
t p
ha
se
s
G2/M
48h 11.66 14.01 12.38 8.14 14.46 10.99
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